Insider · CIK 0001357554
Burshtine Michael
Reports to the SEC for 1 company · NEW YORK, NY
Transactions
10
Companies
1
Filings
3
CIK
0001357554
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2008-01-04 | Omrix Biopharmaceuticals, Inc.M Exercise/Conversion | +$202K |
| 2008-01-04 | Omrix Biopharmaceuticals, Inc.S Sale | −$1.11M |
| 2008-01-03 | Omrix Biopharmaceuticals, Inc.M Exercise/Conversion | +$39.2K |
| 2008-01-03 | Omrix Biopharmaceuticals, Inc.S Sale | −$215K |
| 2008-01-03 | Omrix Biopharmaceuticals, Inc.M Exercise/Conversion | +$62.5K |
| 2008-01-03 | Omrix Biopharmaceuticals, Inc.S Sale | −$155K |
| 2008-01-03 | Omrix Biopharmaceuticals, Inc.Stock OptionM Exercise/Conversion | — |
| 2008-01-02 | Omrix Biopharmaceuticals, Inc.M Exercise/Conversion | +$434K |
| 2008-01-02 | Omrix Biopharmaceuticals, Inc.S Sale | −$2.41M |
| 2007-06-18 | Omrix Biopharmaceuticals, Inc.Put Options (right to sell)P Purchase | +$2,985 |
Recent filings
- 4Omrix Biopharmaceuticals, Inc.0001209191-08-002277SEC(opens sec.gov)
- 4Omrix Biopharmaceuticals, Inc.0001209191-08-001649SEC(opens sec.gov)
- 4Burshtine Michael0001209191-07-037852SEC(opens sec.gov)
Companies
Address
C/O OMRIX BIOPHARMACEUTICALS, INC. 630 FIFTH AVENUE, 22ND FLOOR
NEW YORK, NY, 10111